PRIVIUM FUND MANAGEMENT B.V. Alnylam Pharmaceuticals, Inc. Transaction History

PRIVIUM FUND MANAGEMENT B.V. portfolio value:

$440,000
portfolio value

PRIVIUM FUND MANAGEMENT B.V. quarter portfolio value change:

+37.24%
quarter

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -80.00% -8.4K shares -1.09M $200.16 2.1K
Q2 2022 share Increase +90.91% 5K shares 633K $145.85 10.5K
Q1 2022 share Increase +129.17% 3.1K shares 488K $163.29 5.5K
Q4 2021 share Increase 0.00% 2.4K shares 410K $171.03 2.4K